Within the FDA’s guidance document issued in August 2023: Postmarketing Approaches to Obtain Data on Populations Underrepresented in Clinical Trials for Drugs and Biological ...
In 2022, the FDA provided draft guidance around diversity plans for sponsors to improve the enrollment of clinical trial participants from underrepresented racial and ethnic ...
We have seen clinical research sites accelerate their patient enrollment timeline by four weeks. We have also seen sites enroll 41% more patients in a clinical trial than industry ...
Only about 5% of rare diseases have at least one approved treatment available for affected patients. To increase the availability of care options in this therapeutic area, sponsors ...
Even if your clinical trial enrollment is on track, it is still worthwhile to invest in making recruitment the smoothest–and fastest–it can be. Optimizing your approach with deeper ...
.png?width=64&name=OST%20Transparent%20(1).png)
